From: Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
Days of treatment | ||||
---|---|---|---|---|
Fatty acid | Basal 1 | 30 | 60 | Basal 2 |
16:0 | 22.0 ± 1.0a | 19.0 ± 1.3a | 17.0 ± 1.4b | 23.8 ± 0.9a |
16:1 | 0.3 ± 0.05a | 1.0 ± 0.2b | 1.0 ± 0.1b | 1.3 ± 0.2b |
18:0 | 20.4 ± 0.3a | 22.0 ± 0.5b | 23.0 ± 0.4b | 19.3 ± 0.2c |
18:1 | 14.7 ± 0.4 | 14.3 ± 0.5 | 14.7 ± 1.3 | 14.2 ± 0.6 |
18:2 n-6 | 10.7 ± 0.4 | 11.0 ± 0.5 | 10.5 ± 1.0 | 10.6 ± 0.5 |
20:3 n-6 | 1.9 ± 0.1 | 1.6 ± 0.1 | 2.1 ± 0.2 | 1.6 ± 0.1 |
20:4 n-6 | 19.4 ± 0.9a | 19.0 ± 0.7a | 20.6 ± 0.7a | 15.7 ± 0.7b |
22:4 n-6 | 0.5 ± 0.1a | 0.4 ± 0.05a | 0.5 ± 0.1a | 0.2 ± 0.02b |
22:5 n-6 | 4.7 ± 0.5 | 4.1 ± 0.3 | 4.7 ± 0.3 | 3.5 ± 0.2 |
22:5 n-3 | 2.6 ± 0.2a | 2.3 ± 0.2ab | 2.6 ± 0.2a | 1.9 ± 0.1b |
22:6 n-3 | 4.7 ± 0.3 | 5.6 ± 0.5 | 5.0 ± 0.5 | 4.2 ± 0.3 |